drugset / Trial / NCT00735475
A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this study is to determine the immunogenicity and safety profile of CSL Limited's Influenza Virus Vaccine compared to a US Licensed Comparator Influenza Virus Vaccine.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-01
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Afluria | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Influenza Virus Vaccine | Vaccine | 0.5 ml | Intramuscular |